Voices
Laura Attardi: A Step Toward Drugging Undruggable p53 in Lung Adenocarcinoma

Laura Attardi: A Step Toward Drugging Undruggable p53 in Lung Adenocarcinoma

Laura Attardi, Professor at Stanford University, shared Cancer Discovery’s post on X, adding:

“Thrilled to share our deconstruction of a p53 therapeutic response in LUAD- a step toward drugging undruggable p53!

Thanks to our amazing team!”

Quoting Cancer Discovery’s post:

“Now online: p53 Drives Lung Cancer Regression through a TSC2/TFEB-Dependent Senescence Program.”

Title: p53 Drives Lung Cancer Regression through a TSC2/TFEB-Dependent Senescence Program

Authors: Mengxiong Wang, Kathryn T. Bieging-Rolett, Alyssa M. Kaiser, Colleen A. Brady, John H. Lockhart, Sofia Ferreira, Kha T. Nguyen, Arati Rajeevan, Simone A. Evans, Tianyu Zhao, Nitin Raj, Arielle Elkrief, Sam E. Tischfield, Marc Ladanyi, Michael G. Ozawa, Nam Q. Bui, Christopher T. Chen, Elsa R. Flores, Laura D. Attardi

Read the Full Article on Cancer Discovery

Laura Attardi: A Step Toward Drugging Undruggable p53 in Lung Adenocarcinoma

More posts featuring Laura Attardi.

 

Alyssa M. Kaiser Arati Rajeevan Arielle Elkrief cancer Christopher T. Chen Colleen A. Brady Elsa R. Flores John H. Lockhart Kathryn T. Bieging-Rolett Kha T. Nguyen Laura Attardi Laura D. Attardi Marc Ladanyi Mengxiong Wang Michael G. Ozawa Nam Q. Bui Nitin Raj OncoDaily Oncology Sam E. Tischfield Simone A. Evans Sofia Ferreira Tianyu Zhao